Project Grant HT94252411001
Award Date
11/15/24
Completion Date
11/14/26
Dollars Obligated
$301K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
This $1,347,118 Project Grant was awarded on May 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research conducted by the University of Miami to target KIF20A, a kinesin with a novel, non-canonical role in castration-resistant prostate cancer. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research investigating medical...
The University of Miami has been awarded a $1,700,000.00 Project Grant from the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant will support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research funded under this 2-year grant, with a performance period from September 15, 2024 to September 14, 2026, will explore innovative...
This federal Project Grant award of $1,535,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is funding research at the University of Miami's School of Medicine targeting the reflux-activated oncogenic mRNA translation program in esophageal adenocarcinoma. The 3-year award, which began on July 1, 2025, aims to transform healthcare for military service members, veterans, and the broader public through innovative and...
The University of Miami was awarded a $1,534,998 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from August 15, 2023 to August 14, 2026, will fund research on the role of diffuse large B-cell lymphoma genome complexity in shaping immune responses to anti-CD19 chimeric antigen receptor T-cell therapies. As a non-profit educational institution and experienced federal grant recipient, the University of...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,352,128.00 to the University of Miami for the development of human iPSC-derived chromaffin cell transplants for the treatment of chronic pain. The three-year award, which began on July 15, 2024 and runs through July 14, 2027, supports the university's research to investigate innovative therapeutic approaches for addressing chronic pain conditions...
The University of Miami received a $153,500 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENGINEERING TARGETED EXOSOME-BASED THERAPEUTICS FOR REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER". The 2-year award period runs from February 15, 2024 to February 14, 2026. The Project Grant supports the university's work to develop novel...
The University of Miami received a $921,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 15, 2021 will support single-cell analysis of LAG3 checkpoint inhibition in metastatic uveal melanoma. Through this research, the University aims to transform health care for service members and the public by investigating medical solutions for the...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $894,330.00 to the University of Miami to conduct research targeting axonal regeneration pathways as a therapeutic approach to amyotrophic lateral sclerosis (ALS). The research project aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions. The award period runs from February...
This $1,175,982 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a telehealth intervention aimed at improving quality of life and pancreatic cancer survivorship. The grant, awarded to the Beckman Research Institute of the City of Hope, a nonprofit research organization, will fund the development and implementation of this telehealth program over a 3-year period from August 2024 to July 2027. The project will leverage...
The University of Miami will receive $921,000 through a four-year Project Grant from the Defense Health Agency's Military Medical Research and Development program to conduct research aimed at preventing hair loss in ovarian cancer chemotherapy. The grant period runs from October 1, 2023 through September 30, 2027. Through this award, the University of Miami will leverage its expertise in cancer research to investigate medical solutions that can help reduce the side effects of chemotherapy and...